NCT07270900

Brief Summary

The purpose of this study is to conduct a mindfulness-based intervention for adolescents referred for prediabetes or type 2 diabetes treatment to 1) evaluate feasibility and acceptability of the intervention for future research and clinical use and 2) explore secondary health outcomes related to diabetes prevention and care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
Last Updated

December 8, 2025

Status Verified

November 1, 2025

Enrollment Period

1.5 years

First QC Date

November 14, 2025

Last Update Submit

November 26, 2025

Conditions

Keywords

mindfulness based intervention

Outcome Measures

Primary Outcomes (7)

  • Participation

    Study Participation Rate: Number of participants who consented to take part in the study divided by the number of patients approached. We will also document reasons for refusal to participate in the study.

    3 months

  • Acceptability

    L2B Program Questionnaires Post-study guided interview: 1. What did you like about participating in this study? 2. What did you dislike about participating in this study? 3. What were your expectations from participating in this study? 4. Were those expectations met?

    12 months

  • Recruitment

    Time to Recruit: Time required to attain the needed sample for each recruitment wave

    3 months

  • Attendance

    Attendance: Attendance at each intervention session will be recorded.

    4 months

  • Retention

    Study Retention Rate: Number of participants in a study arm who remain in the study and maintain communication with study staff (regardless of session attendance) divided by the number of participants enrolled in the study.

    12 months

  • Completion

    Study Completion Rate: Number of participants who complete all assessments divided by the number of participants enrolled in the study arm.

    12 months

  • Data Completeness

    Data Completeness: Percentage of questionnaires/study measures completed.

    12 months

Secondary Outcomes (3)

  • Height from electronic medical record

    12 months

  • HbA1c from electronic medical record

    12 months

  • Weight from the electronic medical record

    12 months

Other Outcomes (6)

  • Anxiety symptoms

    12 months

  • Depression symptoms

    12 months

  • Perceived Stress Scale

    12 months

  • +3 more other outcomes

Study Arms (1)

Learn to Breathe Group Program

EXPERIMENTAL

All study participants take part in the L2B MBI

Procedure: Mindfulness Based Group

Interventions

L2B is a manualized 12-week curriculum that teaches a variety of mindfulness skills including breath awareness, body scanning, mindful eating, sitting meditation, loving kindness practice, and mindful movement. Weekly group sessions will last 45-60 minutes. Participants will be invited to engage in daily practice of mindfulness skills (home practice).

Learn to Breathe Group Program

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 12-18 years
  • Referred to clinic for treatment of prediabetes or type 2 diabetes
  • English speaking

You may not qualify if:

  • Diagnosed cognitive disabilities
  • Inability to attend visits due to individual schedules

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riley Diabetes CLinic

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Tamara S Hannon, MD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

November 14, 2025

First Posted

December 8, 2025

Study Start

February 1, 2023

Primary Completion

July 30, 2024

Study Completion

July 30, 2025

Last Updated

December 8, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared, as the data for this study is strictly confidential.

Locations